PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics
Open Access
- 27 August 2019
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 19 (1) , 1-13
Abstract
Advanced stage laryngeal squamous cell carcinoma (LSCC) presents a poor prognosis; thus, there is a great need to identify novel prognostic molecular markers. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) is thought to be a novel prognostic factor in several cancers, but its role in LSCC remains unknown. Cancer stem cells (CSCs) are responsible for most instances of tumor recurrence and the development of drug resistance and have been proven to be present in head and neck cancers. Our preliminary study indicated that PLOD2 was elevated in LSCC tissues; therefore, we hypothesized that PLOD2 is related to the prognosis of LSCC patients and aimed to explore the role and underlying mechanism of PLOD2 in LSCC. We validated the prognostic role of PLOD2 in 114 LSCC patients by immunohistochemistry. Stable PLOD2-overexpressing Hep-2 and FaDu cells were established and assessed by molecular biology and biochemistry methods both in vitro and in vivo. We confirmed that PLOD2 overexpression was correlated with poor prognosis in LSCC patients. PLOD2 overexpression strengthened the CSC-like properties of Hep-2 and FaDu cells, activated the Wnt signaling pathway and conferred drug resistance in LSCC in vitro and in vivo. We found that PLOD2 could serve as a prognostic marker in patients with LSCC and confer drug resistance in LSCC by increasing CSC-like traits; in addition, a Wnt-responsive CSC pathway was identified.Keywords
Funding Information
- Guangzhou Science, Technology and Innovation Commission (201607010389)
This publication has 36 references indexed in Scilit:
- Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cellsSeminars in Cancer Biology, 2018
- MicroRNAs and breast cancer stem cells: Potential role in breast cancer therapyJournal of Cellular Physiology, 2018
- Prostate Stem Cells and Cancer Stem CellsCold Spring Harbor Perspectives in Medicine, 2018
- Cancer stem cells: Regulation programs, immunological properties and immunotherapySeminars in Cancer Biology, 2018
- Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancerNature Cell Biology, 2018
- Ovarian cancer stem cells: A target for oncological therapyAdvances in Clinical and Experimental Medicine, 2018
- Brain Cancer Stem Cells in Adults and Children: Cell Biology and Therapeutic ImplicationsNeurotherapeutics, 2017
- An update on larynx cancerCA: A Cancer Journal for Clinicians, 2016
- Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAILOncology Research, 2016
- Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell LinesCellular Physiology and Biochemistry, 2015